Time dependent expression of cytokines in Mycobacterium bovis infected cattle lymph nodes

Veterinary Immunology and Immunopathology

Volumn 138, Issue 1-2, 2010, Pages 79-84

  Witchell, J ^a,c   Maddipatla, S V P K ^a   Wangoo, A ^b,d   Vordermeier, M ^b   Goyal, M ^a  

^a UNIVERSITY OF HERTFORDSHIRE   (United Kingdom)

^b VETERINARY LABORATORIES AGENCY   (United Kingdom)

^c WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^d Veterinary Medicines Directorate   (United Kingdom)

Author keywords

Bovine tuberculosis; Cytokines; Formalin fixative; Mycobacterium bovis; Quantitative Polymerase chain reaction

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CATTLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; IMMUNE RESPONSE; LEISHMANIASIS; LYMPH NODE; MYCOBACTERIOSIS; MYCOBACTERIUM BOVIS; NONHUMAN; PROTEIN EXPRESSION; TH1 CELL;

ANIMALS; BASE SEQUENCE; CATTLE; CYTOKINES; DNA PRIMERS; FEMALE; GENE EXPRESSION; INFLAMMATION MEDIATORS; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-4; LYMPH NODES; MALE; RNA, MESSENGER; TIME FACTORS; TUBERCULOSIS, BOVINE; TUMOR NECROSIS FACTOR-ALPHA;

BOS; BOVINAE; MYCOBACTERIUM BOVIS;

EID: 77957687276     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2010.07.004     Document Type: Article

References (31)

1. Anderson C.F., Oukka M., Kuchroo V.J., Sacks D. CD4(+) CD25(-) Foxp3(-) Th1 cells are the source of IL10 mediated immune suppression in chronic cutaneous leishmaniasis. J. Exp. Med. 2007, 204(2):285-297.
2. Badell E., Nicolle F., Clark S., Majlessi L., Boudou F., Martino A., Castello-Branco L., Leclerc C., Lewis D.J., Marsh P.D., Gicquel B., Winter N. Protection against tuberculosis induced by oral prime with Mycobacterium bovis BCG and intranasal subunit boost based on the vaccine candidate Ag85B-ESAT-6 does not correlate with circulating IFN-gamma producing T-cells. Vaccine 2009, 27(1):28-37.
3. Boddu-Jasmine H.C., Witchell J., Vordermeier M., Wangoo A., Goyal M. Cytokine mRNA expression in cattle infected with different dosages of Mycobacterium bovis. Tuberculosis (Edinb.) 2008, 88(6):610-615.
4. Cockle P.J., Gordon S.V., Hewinson R.G., Vordermeier H.M. Field evaluation of a novel differential diagnostic reagent for detection of Mycobacterium bovis in cattle. Clin. Vaccine Immunol. 2006, 13(10):1119-1124.
5. Dean G.S., Rhodes S.G., Coad M., Whelan A.O., Cockle P.J., Clifford D.J., Hewinson R.G., Vordermeier H.M. Minimum effective dose of Mycobacterium bovis in cattle. Infect. Immun. 2005, 73(10):6467-6471.
6. Gerosa F., Nisii C., Righetti S., Micciolo R., Marchesini M., Cazzadori A., Trinchieri G. CD4(+) T cell clones producing both interferon gamma and interleukin 10 pre-dominate in bronchoalveolar lavages of active pulmonary tuberculosis patients. Clin. Immunol. 1999, 92(3):224-234.
7. Griffin J.F., Rodgers C.R., Liggett S., Mackintosh C.G. Tuberculosis in ruminants: characteristic of intra-tonsilar Mycobacterium bovis infection models in cattle and deer. Tuberculosis (Edinb.) 2006, 86(6):404-418.
8. Hickman S.P., Chan J., Salgame P. Mycobacterium tuberculosis induces differential cytokine production from dendritic cells and macrophages with divergent effects on naive T cell polarization. J. Immunol. 2002, 168(9):4636-4642.
9. Jalava K., Jones J.A., Goodchild T., Clifton-Hadley R., Mitchell A., Story A., Watson J.M. No increase in human cases of Mycobacterium bovis disease despite resurgence of infections in cattle in the United Kingdom. Epidemiol. Infect. 2007, 135(1):40-45.
10. Jankovic D., Kullberg M.C., Feng C.G., Goldszmid R.S., Collazo C.M., Wilson M., Wynn T.A., Kamanak M., Flavell R.A., Sher A. Conventional T-bet(+)Foxp3(-) Th1 cells are the major source of host-protective regulatory IL10 during intracellular protozoan infection. J. Exp. Med. 2007, 204(2):273-283.
11. Joardar S.N., Ram G.C., Goswami T. Dynamic changes in cellular immune responses in experimental bovine tuberculosis. Med. Sci. Monit. 2002, 8(11):471-480.
12. Locksley R.M., Heinzel F.P., Sadick M.D., Holaday B.J., Gardner K.D. Murine cutaneous leishmaniasis: susceptibility correlates with differential expansion of helper T cell subsets. Ann. Inst. Pasteur Immunol. 1987, 138(5):744-749.
13. Melby P.C., Andrade-Narvaez F.J., Darnell B.J., Valencia-Pacheco G., Tryon V.V., Palomo-Cetina A. Increased expression of proinflammatory cytokines in chronic lesions of human cutaneous leishmaniasis. Infect. Immun. 1994, 62(3):837-842.
14. Munro J.M., Pober J.S., Cotran R.S. Tumour necrosis factor and interferon-gamma induce distinct patterns of endothelial activation and associated leukocyte accumulation in skin of Papio anubis. Am. J. Pathol. 1989, 135(1):121-133.
15. Orme I. Cellular and genetic mechanisms underlying susceptibility of animal models to tuberculosis infection. Novartis Found. Symp. 1998, 217:112-117.
16. Palmer M.V., Whipple D.L., Olsen S.C., Jacobson R.H. Cell mediated and humoral immune responses of white-tailed deer experimentally infected with Mycobacterium bovis. Res. Vet. Sci. 2000, 68(1):95-98.
17. Palmer M.V., Waters W.R., Thacker T.C. Lesion development and immunohistochemical changes in granulomas from cattle experimentally infected with Mycobacterium bovis. Vet. Pathol. 2007, 44(6):863-874.
18. Pollock J.M., McNair J., Welsh M.D., Girvin R.M., Kennedy H.E., Mackie D.P., Neill S.D. Immune responses in bovine tuberculosis. Tuberculosis (Edinb.) 2001, 81(1-2):103-107.
19. Reynolds D. A review of tuberculosis science and policy in Great Britain. Vet. Microbiol. 2006, 112:119-126.
20. Rhodes S.G., Buddle B.M., Hewinson R.G., Vordermeier H.M. Bovine tuberculosis: immune responses in the peripheral blood and at the site of active disease. Immunology 2000, 99:195-202.
21. Schultz R.M., Kleinschmidt W.J. Functional identity between murine gamma interferon and macrophage activating factor. Nature 1983, 305(5931):239-240.
22. Scott P., Natovitz P., Coffman R.L., Pearce E., Sher A. Immunoregulation of cutaneous leishmaniasis. T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens. J. Exp. Med. 1988, 168(5):1675-1684.
23. Sopp P., Coad M., Hewinson G., Howard C.J., Cheallaigh C.N., Keane J., Harris J., Hope J.C. Development of a simple, sensitive, rapid test which discriminates BCG-vaccinated from Mycobacterium bovis-infected cattle. Vaccine 2008, 26(43):5470-5476.
24. Thacker T.C., Palmer M.V., Waters W.R. Associations between cytokine gene expression and pathology in Mycobacterium bovis infected cattle. Vet. Immunol. Immunopathol. 2007, 119(3-4):204-213.
25. Villarreal-Ramos B., McAulay M., Chance V., Martin M., Morgan J., Howard C.J. Investigation of the role of CD8+ T cells in bovine tuberculosis in vivo. Infect. Immun. 2003, 71(8):297-303.
26. Vordermeier H.M., Whelan A., Cockle P.J., Farrant L., Palmer N., Hewinson R.G. Use of synthetic peptides derived from the antigens ESAT-6 and CFP-10 for differential diagnosis of bovine tuberculosis in cattle. Clin. Diagn. Lab. Immunol. 2001, 8(3):571-578.
27. Welsh M.D., Cunningham R.T., Corbett D.M., Girvin R.M., McNair J., Skuce R.A., Bryson D.G., Pollock J.M. Influence of pathological progression on the balance between cellular and humoral immune responses in bovine tuberculosis. Immunology 2005, 114(1):101-111.
28. Witchell J., Varshney D., Gajjar T., Wangoo A., Goyal M. RNA isolation and quantitative PCR from HOPE and formalin fixed bovine lymph node tissues. Pathol. Res. Pract. 2008, 204(2):105-111.
29. Widdison S., Schreuder L.J., Villarreal-Ramos B., Howard C.J., Watson M., Coffey T.J. Cytokine expression profiles of bovine lymph nodes: effects of Mycobacterium bovis infection and bacille Calmette-Guerin vaccination. Clin. Exp. Immunol. 2006, 144(2):281-289.
30. Widdison S., Watson M., Coffey T.J. Correlation between lymph node pathology and chemokine expression during bovine tuberculosis. Tuberculosis (Edinb.) 2009, 89(6):417-422.
31. Vordermeier H.M., Chambers M.A., Cockle P.J., Whelan A.O., Simmons J., Hewinson R.G. Correlation of ESAT-6 specific gamma interferon production with pathology in cattle following Mycobacterium bovis BCG vaccination against experimental bovine tuberculosis. Infect. Immun. 2002, 70(6):3026-3032.